Related Experiment Videos
Towards a novel toxicity prediction pipeline, combining PBPK models and mechanistic cellular adversity models
Elsje J Burgers1, Raju P Sharma1, Tamara Y Danilyuk1
1Division of Cell Systems and Drug Safety, Leiden Academic Centre for Drug Research, Leiden University, The Netherlands.
None:
There is a strong need for animal-free methods that properly predict drug adversity. Especially drug-induced liver injury (DILI) is a common adverse effect that is difficult to predict with current methodology. In this study, we developed a data-driven computational adversity model for predicting the relative number of apoptotic cells in vitro, based on stress pathway activity invoked by exposure of liver cells to nitrofurantoin, diclofenac, and ketoconazole. Next, we adapted this adversity model to represent an in vivo situation and developed physiologically-based pharmacokinetic (PBPK) models for all three drugs to simulate the concentration of the drugs in the liver of humans and rats. Coupling the PBPK, stress pathway and adversity models generated quantitative systems toxicology models for rats and humans at clinically-relevant doses. For all three drugs, low levels of toxicity were predicted in rats and humans, which is consistent with in vivo observations. A detailed analysis of modifying factors (sex, age) showed that the amount of apoptotic cells is expected to increase for females and elderly people compared to males. Coupling the different models generated a novel modelling pipeline that is an important step towards in silico DILI predictions.
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Mechanistic Models: Overview of Compartment Models
Pharmacodynamic Models: Overview
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Compartment Models in Individual and Population Analysis